Arvinas (ARVN) Interest Coverage Ratio Growth (1y) (2018 - 2026)
Arvinas (ARVN) Interest Coverage Ratio Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | -347.04% |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - | 73.00% |
| 10 | Arvinas | 533.12 Mn | -81.78 Mn | - | -370.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -370.36% |
| Dec 31, 2025 | -476.80% |
| Sep 30, 2025 | 73.85% |
| Jun 30, 2025 | 17.44% |
| Mar 31, 2025 | 114.53% |
| Dec 31, 2024 | 90.22% |
| Sep 30, 2024 | -181.06% |
| Jun 30, 2024 | -71.82% |
| Mar 31, 2024 | -99.46% |
| Dec 31, 2023 | -74.92% |
| Sep 30, 2023 | -89.08% |
| Jun 30, 2023 | 84.68% |
| Mar 31, 2023 | -120.75% |
| Dec 31, 2022 | -19.37% |
| Sep 30, 2022 | -5,506.66% |
| Jun 30, 2022 | -50,459.20% |
| Mar 31, 2022 | -20.63% |
| Dec 31, 2021 | -244.22% |
| Sep 30, 2021 | 98.28% |
| Jun 30, 2021 | 97.36% |